Technological changes in medicine and healthcare are revolutionary and will have greater impact on every stakeholder including researchers, consumers, medical doctors, industry professionals.
The recent developments and latest trends in healthcare and technology are well compiled to help you keep pace with the dynamic needs of the industry.
Asian Hospital & Healthcare Management brings you the correlation between Technology and better business outcomes and the underlying economics for a more holistic approach in healthcare delivery.
Upcoming Issue 31st April 2015 special issue exclusively on 'Technology in Healthcare' just for you!
Please find the below link of Media Pack http://www.asianhhm.com/mediapacks wherein all the advertising details are mentioned.
Asian hospitals and healthcare managementyahyasultan
The market for medical equipment and technology in Asia is booming. In excess of US$24 billion is being spent each year with major hospital construction projects underway in nearly all of the Asian countries. Government spending on the health sector is expected to grow at approximately 8-10% per annum.
- The document proposes establishing a medical supplies business in Oman to import and distribute high-quality medical equipment and products.
- It analyzes Oman's healthcare market, noting a need for improved specialized and territory care, and outlines plans to source products from Dubai, Egypt, India and locally while also promoting medical tourism to India.
- The proposal requests an investment of approximately $2.6 million USD to fund infrastructure, materials, vehicles, licenses and initial working capital over the first five years, with a projected 30% gross profit and substantial growth.
Market Access, Pricing and Reimbursement streamlinedWang-yee Liu
This document provides an agenda for the "Market Access, Pricing and Reimbursement 2016 Europe" conference taking place on June 9-10, 2016 in London. The agenda includes presentations and speakers on topics related to market access strategies, challenges in pharmaceutical pricing and reimbursement, and maximizing access in emerging markets. Key industry experts scheduled to speak include leaders from pharmaceutical companies such as Celgene, Sanofi, Alcon, and Daiichi Sankyo. The conference aims to provide a platform for stakeholders to discuss macroeconomic factors, policies, and drivers influencing the pharmaceutical industry.
Oncology biosimilars Market Report in PPT: Top Companies, Trends and Future D...IMARC Group
The document summarizes a report by IMARC Group on the global oncology biosimilars market. It discusses the growth of the market driven by the rising prevalence of cancer and upcoming patent expiries. Oncology biosimilars are similar to original biologics but are more affordable, improving access to treatment. The report analyzes the market by drug type, distribution channel, and region. It also profiles the major players in the industry.
This document presents an analysis of the current state of the biosimilar market as well as its perspectives of evolution, with a particular focus on the French market
This document provides information about the "Market Access, Pricing and Reimbursement 2016 Europe" conference, including details about its location, dates, sponsors, exhibitors, featured speakers and topics. Some of the key points mentioned are that the conference will take place from June 9-10, 2016 in London and will provide a platform for stakeholders in the pharmaceutical industry to discuss challenges and opportunities in areas like market access strategies, pricing and reimbursement trends, emerging markets, and use of real-world evidence. The document also lists over 20 industry experts who will be speaking, along with their titles and companies.
Asian hospitals and healthcare managementyahyasultan
The market for medical equipment and technology in Asia is booming. In excess of US$24 billion is being spent each year with major hospital construction projects underway in nearly all of the Asian countries. Government spending on the health sector is expected to grow at approximately 8-10% per annum.
- The document proposes establishing a medical supplies business in Oman to import and distribute high-quality medical equipment and products.
- It analyzes Oman's healthcare market, noting a need for improved specialized and territory care, and outlines plans to source products from Dubai, Egypt, India and locally while also promoting medical tourism to India.
- The proposal requests an investment of approximately $2.6 million USD to fund infrastructure, materials, vehicles, licenses and initial working capital over the first five years, with a projected 30% gross profit and substantial growth.
Market Access, Pricing and Reimbursement streamlinedWang-yee Liu
This document provides an agenda for the "Market Access, Pricing and Reimbursement 2016 Europe" conference taking place on June 9-10, 2016 in London. The agenda includes presentations and speakers on topics related to market access strategies, challenges in pharmaceutical pricing and reimbursement, and maximizing access in emerging markets. Key industry experts scheduled to speak include leaders from pharmaceutical companies such as Celgene, Sanofi, Alcon, and Daiichi Sankyo. The conference aims to provide a platform for stakeholders to discuss macroeconomic factors, policies, and drivers influencing the pharmaceutical industry.
Oncology biosimilars Market Report in PPT: Top Companies, Trends and Future D...IMARC Group
The document summarizes a report by IMARC Group on the global oncology biosimilars market. It discusses the growth of the market driven by the rising prevalence of cancer and upcoming patent expiries. Oncology biosimilars are similar to original biologics but are more affordable, improving access to treatment. The report analyzes the market by drug type, distribution channel, and region. It also profiles the major players in the industry.
This document presents an analysis of the current state of the biosimilar market as well as its perspectives of evolution, with a particular focus on the French market
This document provides information about the "Market Access, Pricing and Reimbursement 2016 Europe" conference, including details about its location, dates, sponsors, exhibitors, featured speakers and topics. Some of the key points mentioned are that the conference will take place from June 9-10, 2016 in London and will provide a platform for stakeholders in the pharmaceutical industry to discuss challenges and opportunities in areas like market access strategies, pricing and reimbursement trends, emerging markets, and use of real-world evidence. The document also lists over 20 industry experts who will be speaking, along with their titles and companies.
Presentation of the "Smart Field Force Framework" which has been developed to help pharma companies design the best organizational model to support the right strategy and tactics
Description of the "KAM Expert Wheel" which is a method to structure the activities of Key Account Managers and help them cope with the complexity of their task
Market Access - Getting ready for Personalized Medicine!executiveinsight
A presentation outlining the potential gains, pitfalls and strategies needed to realize the value in Personalized Medicine (Companion Diagnostics, Therapies).
The document outlines a business plan for starting a medical device supply company in South Africa. It provides an overview of the market opportunity in South Africa, including growth rates in the medical device industry and the types of products sold. It then outlines 7 steps to starting the business, including selecting a niche market, obtaining necessary licenses and permits, setting up inventory, and marketing strategies. Key points about the South African market such as the size of the public and private hospital sector and available financing options are also summarized.
The CEMA South Africa 2016 summit will bring together senior pharmaceutical executives, government representatives, private health insurers, and other key decision makers. The goal is to promote collaboration across stakeholders and address barriers to ensuring patient access to essential medicines in South Africa. Over two days, the event will feature panels, case studies, and networking opportunities. Attendees will learn strategies for optimizing pricing and supply, integrating marketing and market access, and achieving real collaboration with payers to streamline market access. The speaker faculty includes leaders from major pharmaceutical companies, health insurers, and academic institutions.
Market access the challenges for medical devices Amy Morgan
With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted…
Market Research Report : Medical diagnostics market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract :
Netscribes’ latest market research report titled Medical Diagnostics Market in India 2014 analyses the growth of the market due to cutting edge technology which provides better disease diagnosis. The Indian diagnostics market can be divided into equipment, reagents and services. The service sector is characterized by a large number of laboratories in the unorganized sector, which are clustered in the suburban areas and metros. In order to have better regulations and proper definition for the market a clear and structured format is being established. The laboratories are rapidly expanding using various business models. Large numbers of laboratories are registered only with the state health departments and not recognized by NABL (National Accreditation Board for Testing and Calibration Laboratories under Department of Science and Technology, Govt. of India).
The market is driven by increasing number of lifestyle diseases, rise in life expectancy due to preventive healthcare practices and increasing medical tourism. Currently there is trend of diagnostic medical imaging due to innovation in the technology sector which is helping the market to grow. Few numbers of accredited labs and high dependence on imported medical diagnostics products are the challenges this market is facing. Even though a range of diagnostic tests for various diseases are available in the market, there is a need for more reliable and better diagnostics. The market is dominated by private diagnostics companies in India who are expanding in Tier I and Tier II cities. Providing after-sales services for medical instruments and competitive pricing of the tests will catalyze the growth of the diagnostic sector.
Table of Contents :
Slide 1: Executive Summary
Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 – Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 – Jul 2013), Exchange Rate: Half Yearly (Aug 2013 – Jan 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)
Introduction
Slide 5: Medical Diagnostics Sector – Overview
Market Overview
Slide 6: Medical Diagnostics– Market Overview Forecasted Market Size and Growth (Value-Wise; 2013 – 2018e)
Slide 7: Medical Diagnostics Market – Overview of Franchise Business Model
Slide 8: Medical Diagnostics Market – Overview of Other Business Models
Slide 9: Accreditation of Laboratories
Slide 10: Technological Developments Used for the Diagnosis of a Wide Spectrum of Infectious Diseases
Drivers & Challenges
Slide 11: Medical Diagnostics Market – Drivers and Challenges summary
Slide 12-16: Drivers
Slide 17-18: Challenges
Trends
Slide 19: Trends – Summary
Slide 20-22: Trends
Go
Greetings from Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming “9th Pharmacovigilance 2015” The conference will Be held on 2nd September 2015, Kohinoor Continental Hotel, Mumbai, India. Please find the detailed agenda for the same with this email.
FMD:- + 91 9171350244 or deepak@virtueinsight.co.in, deepakrajvirtueinsight@gmail.com
The purpose of this report is to provide key information and robust analyses to better optimize drug valuation, from the pharmaceutical companies perspective
This report analyzes the current situation and the key trends of the French Pharma market by the end of 2022 to provide pharma companies with key strategic insights
Healthcare and Pharma Brands across APAC NationsSumit Roy
This document summarizes key insights from an issue of the IMS Asia-Pacific Insight Magazine. It discusses the burgeoning over-the-counter (OTC) drug market in Asia-Pacific, which has significantly outpaced global OTC growth for the past three years. Within Asia-Pacific, developed OTC markets like Australia, Japan, Singapore, and the Philippines have established norms of self-medication and OTC advertising. However, developing markets still have developing consumer mindsets and less accessibility. The document advocates understanding differences between developed and developing markets to effectively capture opportunities in the growing Asia-Pacific OTC market.
This document discusses trends in emerging pharmaceutical markets, focusing on Brazil, Russia, India, and China. It provides an overview of the current healthcare systems and pharmaceutical markets in each country. Some key points discussed include growth patterns in developed markets flattening while emerging markets see significant growth potential. The document also outlines future trends in each country such as increasing regulation, emphasis on generics, and strategies pharmaceutical companies can employ to succeed in these emerging markets.
Thailand has developed a cutting-edge biotechnology industry over the past two decades, with applications across medical, agricultural, aquatic, and industrial fields. The biotechnology sector was established in 1983 with the creation of the National Center for Genetic Engineering and Biotechnology and has grown to include around 200 firms with a total market value of over $2 billion. The Thai government aims to make Thailand a leader in biotechnology in Asia and has implemented policies to strengthen R&D and commercial applications of biotechnology, focusing on agriculture and food, medicine and healthcare, bioenergy, and bioindustries.
Advanced Sales Force Remodeling Strategies in a Multi-Channel Environment Ind...Moch Kurniawan
The document discusses strategies for pharmaceutical companies in emerging markets like Indonesia. It notes that emerging markets have great potential but also diversity in healthcare infrastructure development. Within emerging markets, there are three clusters of markets with differing levels of readiness: BRICMT countries, second-tier countries like Indonesia, Vietnam and Thailand, and African countries. The global pharmaceutical market is expected to be worth $1.6 trillion by 2020, with emerging markets playing an important role in industry growth. Pharmaceutical companies must adapt to new realities in emerging markets like price pressures, demand for low-cost generics, and healthcare reforms.
French generics market attractiveness 2017 - 2022 excerptJean-Michel Peny
This excerpt of a report published in 2017 describes and explains the dynamics of the French generics and biosimilars markets in France, and evaluate their attractiveness by 2022
La IX Jornada Internacional ISMS Forum Spain se celebró el 26 de mayo de 2011 y trató sobre amenazas, cumplimiento normativo, riesgos y privacidad desde una perspectiva global.
Presentation of the "Smart Field Force Framework" which has been developed to help pharma companies design the best organizational model to support the right strategy and tactics
Description of the "KAM Expert Wheel" which is a method to structure the activities of Key Account Managers and help them cope with the complexity of their task
Market Access - Getting ready for Personalized Medicine!executiveinsight
A presentation outlining the potential gains, pitfalls and strategies needed to realize the value in Personalized Medicine (Companion Diagnostics, Therapies).
The document outlines a business plan for starting a medical device supply company in South Africa. It provides an overview of the market opportunity in South Africa, including growth rates in the medical device industry and the types of products sold. It then outlines 7 steps to starting the business, including selecting a niche market, obtaining necessary licenses and permits, setting up inventory, and marketing strategies. Key points about the South African market such as the size of the public and private hospital sector and available financing options are also summarized.
The CEMA South Africa 2016 summit will bring together senior pharmaceutical executives, government representatives, private health insurers, and other key decision makers. The goal is to promote collaboration across stakeholders and address barriers to ensuring patient access to essential medicines in South Africa. Over two days, the event will feature panels, case studies, and networking opportunities. Attendees will learn strategies for optimizing pricing and supply, integrating marketing and market access, and achieving real collaboration with payers to streamline market access. The speaker faculty includes leaders from major pharmaceutical companies, health insurers, and academic institutions.
Market access the challenges for medical devices Amy Morgan
With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted…
Market Research Report : Medical diagnostics market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract :
Netscribes’ latest market research report titled Medical Diagnostics Market in India 2014 analyses the growth of the market due to cutting edge technology which provides better disease diagnosis. The Indian diagnostics market can be divided into equipment, reagents and services. The service sector is characterized by a large number of laboratories in the unorganized sector, which are clustered in the suburban areas and metros. In order to have better regulations and proper definition for the market a clear and structured format is being established. The laboratories are rapidly expanding using various business models. Large numbers of laboratories are registered only with the state health departments and not recognized by NABL (National Accreditation Board for Testing and Calibration Laboratories under Department of Science and Technology, Govt. of India).
The market is driven by increasing number of lifestyle diseases, rise in life expectancy due to preventive healthcare practices and increasing medical tourism. Currently there is trend of diagnostic medical imaging due to innovation in the technology sector which is helping the market to grow. Few numbers of accredited labs and high dependence on imported medical diagnostics products are the challenges this market is facing. Even though a range of diagnostic tests for various diseases are available in the market, there is a need for more reliable and better diagnostics. The market is dominated by private diagnostics companies in India who are expanding in Tier I and Tier II cities. Providing after-sales services for medical instruments and competitive pricing of the tests will catalyze the growth of the diagnostic sector.
Table of Contents :
Slide 1: Executive Summary
Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 – Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 – Jul 2013), Exchange Rate: Half Yearly (Aug 2013 – Jan 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)
Introduction
Slide 5: Medical Diagnostics Sector – Overview
Market Overview
Slide 6: Medical Diagnostics– Market Overview Forecasted Market Size and Growth (Value-Wise; 2013 – 2018e)
Slide 7: Medical Diagnostics Market – Overview of Franchise Business Model
Slide 8: Medical Diagnostics Market – Overview of Other Business Models
Slide 9: Accreditation of Laboratories
Slide 10: Technological Developments Used for the Diagnosis of a Wide Spectrum of Infectious Diseases
Drivers & Challenges
Slide 11: Medical Diagnostics Market – Drivers and Challenges summary
Slide 12-16: Drivers
Slide 17-18: Challenges
Trends
Slide 19: Trends – Summary
Slide 20-22: Trends
Go
Greetings from Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming “9th Pharmacovigilance 2015” The conference will Be held on 2nd September 2015, Kohinoor Continental Hotel, Mumbai, India. Please find the detailed agenda for the same with this email.
FMD:- + 91 9171350244 or deepak@virtueinsight.co.in, deepakrajvirtueinsight@gmail.com
The purpose of this report is to provide key information and robust analyses to better optimize drug valuation, from the pharmaceutical companies perspective
This report analyzes the current situation and the key trends of the French Pharma market by the end of 2022 to provide pharma companies with key strategic insights
Healthcare and Pharma Brands across APAC NationsSumit Roy
This document summarizes key insights from an issue of the IMS Asia-Pacific Insight Magazine. It discusses the burgeoning over-the-counter (OTC) drug market in Asia-Pacific, which has significantly outpaced global OTC growth for the past three years. Within Asia-Pacific, developed OTC markets like Australia, Japan, Singapore, and the Philippines have established norms of self-medication and OTC advertising. However, developing markets still have developing consumer mindsets and less accessibility. The document advocates understanding differences between developed and developing markets to effectively capture opportunities in the growing Asia-Pacific OTC market.
This document discusses trends in emerging pharmaceutical markets, focusing on Brazil, Russia, India, and China. It provides an overview of the current healthcare systems and pharmaceutical markets in each country. Some key points discussed include growth patterns in developed markets flattening while emerging markets see significant growth potential. The document also outlines future trends in each country such as increasing regulation, emphasis on generics, and strategies pharmaceutical companies can employ to succeed in these emerging markets.
Thailand has developed a cutting-edge biotechnology industry over the past two decades, with applications across medical, agricultural, aquatic, and industrial fields. The biotechnology sector was established in 1983 with the creation of the National Center for Genetic Engineering and Biotechnology and has grown to include around 200 firms with a total market value of over $2 billion. The Thai government aims to make Thailand a leader in biotechnology in Asia and has implemented policies to strengthen R&D and commercial applications of biotechnology, focusing on agriculture and food, medicine and healthcare, bioenergy, and bioindustries.
Advanced Sales Force Remodeling Strategies in a Multi-Channel Environment Ind...Moch Kurniawan
The document discusses strategies for pharmaceutical companies in emerging markets like Indonesia. It notes that emerging markets have great potential but also diversity in healthcare infrastructure development. Within emerging markets, there are three clusters of markets with differing levels of readiness: BRICMT countries, second-tier countries like Indonesia, Vietnam and Thailand, and African countries. The global pharmaceutical market is expected to be worth $1.6 trillion by 2020, with emerging markets playing an important role in industry growth. Pharmaceutical companies must adapt to new realities in emerging markets like price pressures, demand for low-cost generics, and healthcare reforms.
French generics market attractiveness 2017 - 2022 excerptJean-Michel Peny
This excerpt of a report published in 2017 describes and explains the dynamics of the French generics and biosimilars markets in France, and evaluate their attractiveness by 2022
La IX Jornada Internacional ISMS Forum Spain se celebró el 26 de mayo de 2011 y trató sobre amenazas, cumplimiento normativo, riesgos y privacidad desde una perspectiva global.
Fotos de la VIII Jornada ISMS Forum SpainISMS Forum
La pandemia de COVID-19 ha tenido un impacto significativo en la economía mundial. Muchos países experimentaron fuertes caídas en el PIB y aumentos en el desempleo debido a los cierres generalizados y las restricciones a los viajes. Aunque las vacunas han permitido la reapertura de muchas economías, los efectos a largo plazo de la pandemia en sectores como el turismo y los viajes aún no están claros.
El documento propone varias ideas para generar sensibilización en la sociedad, incluyendo la valorización de profesiones relacionadas a servicios públicos, la equidad de género, eventos de teatro cabaret y una radio comunitaria.
O documento discute como a plataforma web 2.0 permite partilhar informações e colocar os usuários no centro da World Wide Web. Exemplos incluem o YouTube, onde usuários podem carregar e compartilhar vídeos, e a marca AussieBum que promove seus produtos de roupa através de redes sociais e blogs. A web 2.0 também pode ser usada para fins solidários, como arrecadar doações médicas através de apelos online.
Las mejores propuestas para sensibilizar a la sociedadRecrea d
El documento propone varias ideas para generar sensibilización en la sociedad, incluyendo la valorización de profesiones relacionadas a servicios públicos, la equidad de género, eventos de teatro cabaret y una radio comunitaria.
Propuestas para marcas de bebidas alcohólicasRecrea d
Este documento lista doce propuestas de nombres para bebidas alcohólicas, incluyendo Ideamanía, Los Conejito Peluche, Amaranto Chocolatres y Fuga Creativa HPG y LS.
O documento promove cápsulas de óleo de coco como uma alternativa prática para aqueles que não gostam do gosto do óleo de coco puro. As cápsulas de óleo de coco oferecem os mesmos benefícios, são fáceis de tomar com líquido e estimulam a termogênese no corpo, aumentando a queima de calorias.
Los sistemas operativos por servicios ofrecen servicios básicos a los programas de software a través de una interfaz estándar, permitiendo que los programas se ejecuten en diferentes sistemas operativos sin necesidad de modificaciones.
Este documento presenta cuatro equipos creativos de la Facultad de Ciencias Políticas y Sociales de la UNAM que participan en análisis publicitario: Huella digital, Kinich, Espiral 2.0. Cada equipo está afiliado a la carrera de análisis publicitario de la FCPyS.
El documento presenta las calificaciones de 10 estudiantes en las asignaturas de matemáticas, español y ciencias, así como su promedio general. Se incluye el nombre del colegio, la profesora y el año escolar.
Apresentação pisa com alterações e algumas animações finalAndreus Cruz
1) O documento discute os conceitos e práticas da alfabetização científica em sala de aula segundo o teste PISA. 2) O PISA avalia as competências dos estudantes em leitura, matemática e ciências em diversos países a cada 3 anos. 3) São descritos os níveis de proficiência em alfabetização científica avaliados pelo PISA, que incluem a identificação de questões científicas, explicações de fenômenos e uso de evidências.
El documento menciona que es 1 de junio de 2009 y las 08:47 h. Se le dice a la persona que se relaje porque todavía es temprano y se mencionan unas fotos simpáticas. No se proporciona más información relevante.
With a lot of mergers and acquisitions taking place in the Asian markets, and growth being the primary objective of the Asian Pharma industry, it has become evident that the centre stage of global Pharma operations is shifting from the US and Europe to Asia.
Vertical market expansion hc gleikin2013q4campaignGary Leikin
This document provides an overview of vertical market expansion and opportunities in the healthcare technology market. It discusses why companies pursue vertical market expansion, best practices for evaluating opportunities, and risks to avoid. The document analyzes the healthcare industry and trends driving changes, such as a shift to value-based care and managing chronic diseases. It also examines economic factors like the importance of outcomes and return on investment for new technologies. Finally, the document discusses enabling technologies from other industries that could drive advances in medical technology if applied to healthcare challenges.
The document discusses the state of healthcare in the United States, National Imaging Associates (NIA) and their RadMD enterprise portal. It describes how the US healthcare system is large, costly and fragmented. NIA created RadMD to connect physicians, improve information sharing and manage diagnostic imaging costs/quality. RadMD integrates clinical data and transaction processing to facilitate the healthcare process for providers, payers and patients.
Refurbished medical equipment Market PPT 2021: Size, Growth, Demand and Forec...IMARC Group
According to the latest report by IMARC Group, the global refurbished medical equipment market reached a strong growth in 2020.
Refurbished medical equipment are devices that are restored to their original safety and effectiveness.
Planning the marketing of a multi centric diagnostic centreKavita Soni
The document outlines a marketing plan for a new multi-centric diagnostic centre. It discusses identifying target markets through research on demographics, competitors, and customer needs. A SWOT analysis is performed. The pre-commissioning stage involves hiring staff, setting prices, and creating awareness through advertisements. During commissioning, an inauguration event and ongoing promotional activities are planned. Post-commissioning, goals are set to increase referrals and revenue while providing quality service, corporate partnerships, and value-added services to customers.
Planning the marketing of a multi centric diagnostic centre kavitaKavita Soni
The document outlines a marketing plan for a new multi-centric diagnostic centre offering imaging and pathology services. It discusses identifying target markets through research of demographics, competitors, and gaps in the existing market. A SWOT analysis is conducted. The pre-commissioning stage involves hiring staff, setting prices, and creating awareness among doctors. During commissioning, an inauguration event and promotional activities like advertising and press releases are planned. Post-commissioning, long and short-term goals are set around increasing revenue and achieving break-even in three years through continued advertising, physician outreach, and focus on high-value customers.
Marketing Oncology: Service Line StrategiesRenown Health
The document provides an agenda and materials for a webinar on marketing strategies for oncology service lines. It includes discussions on market segmentation, targeting, and positioning for oncology services. Case studies are presented on how Baystate Health launched a free-standing cancer center to improve coordination of services and the patient experience across all touchpoints.
This document discusses marketing techniques and management systems for hospitals. It covers identifying customer needs, developing programs and services to satisfy customers, and performing SWOT and PEST analyses. Various marketing strategies are presented, including the four Ps of marketing (product, place, price, promotion), addressing variables like patients, physicians, employers and lack of patient knowledge. The importance of marketing and management for hospital revenue generation is emphasized.
SMi Group's Inaugural Big Data in Pharma conferenceDale Butler
This document provides information about a conference on big data in the pharmaceutical industry, including an agenda, speaker details, and workshop information. The two-day conference will focus on how big data can be leveraged to enhance research and development, clinical trials, and real-world evidence generation. Highlights include sessions on personalized medicine, predictive analytics, and social media strategies. Post-conference workshops will discuss the legal aspects of cloud computing and designing studies using big data to support drug development and marketing. The event aims to help pharmaceutical companies exploit big data's potential to create better medicines and new revenue streams.
Concord Medical Services Holdings Ltd. is a leading provider of radiotherapy and diagnostic imaging services in China. It operates a nationwide network of 130 centers with 74 hospital partners in 24 provinces. The presentation highlights the company's strong growth, leading market position, and expansion strategies through network growth, new technology, and developing specialty cancer hospitals. Financial results show increasing revenue, profitability, and a solid capital structure to support continued growth.
East African pharmaceuticals seector.pptxWillis Khedia
Zain Pharma Ltd. is exploring opportunities in the East African pharmaceutical market, which has a total market size of USD 2216 million and is growing at a compound annual rate of 11.8%. The East African Community (EAC) has implemented regional plans to reduce pharmaceutical imports and support the expansion of local manufacturers. Kenya represents the most lucrative market in the region, with a pharmaceutical market of over USD 550 million that is projected to grow at 11.8% annually. Zain Pharma has a manufacturing facility in Kenya and is considering technology transfers and partnerships to strengthen its capabilities and better serve the needs of the East African healthcare sector.
This document summarizes a 3-day conference on market access in Latin America for pharmaceutical and medical device companies. Day 1 focuses on the Latin American payer and health technology assessment summit. Day 2 has two streams, one on pharmaceutical market access and one on medical device market access and commercialization. Day 3 is on evidence development in Latin America. There will be over 26 presentations from regional market access leaders, including representatives from health technology assessment agencies, payers, pharmaceutical and medical device companies, policy researchers, and consulting firms. The conference aims to help companies demonstrate product value, understand different market approaches and barriers, and develop strategies for partnering with customers in the complex and dynamic Latin American healthcare markets.
Access 2-healthcare company introduction deck - english - may 2018Access-2-Healthcare
Market Entry for Medical Technology / Medical Device companies, in Asia Pacific, Europe, US
#Commercialisation
#Healthcare
#Regulatory
#Quality
#SoftwareValidation / #Verification
#DueDiligence
#LicenseHolding
#Go-to-MarketStrategy
#MarketStudies
Afripharm Medicals Ltd is an innovative sourcing & distribution pharma and healthcare company, involved in both exclusive representation and African supply of a wide range of quality pharmaceutical ingredients and finished pharma products and formulations.
The document discusses how new technologies are changing healthcare in Central and Eastern Europe. It finds that telemedicine can help address issues like insufficient funds, long wait times, and expensive infrastructure investments. Over 60% of patients in the region are open to telemedicine solutions like teleconsulting and remote monitoring. Telemedicine provides benefits like higher quality care, lower costs, and more efficient use of resources. Factors driving telemedicine adoption include advanced technologies, changing patient demands, and a growing private healthcare market. There is significant interest from private stakeholders in investing in telemedicine. The recommendations are to enhance brands, optimize the patient experience, acquire patients effectively, design new operating models, and leverage collected healthcare data.
This document discusses how life sciences companies can address challenges in the industry by adopting new technologies. It identifies trends putting pressure on companies, such as new regulations and shifting customer expectations. It then presents solutions that technology can provide: a new multi-channel commercial model to better engage customers; business agility through cloud-based platforms to accelerate innovation; and a focus on outcomes through data analytics and patient services to improve care. Adopting modern cloud technologies, the document argues, is key for companies to transform their business models and adapt to changes in the industry environment.
This document provides information about Hays Pharma, a leading global staffing company focused on the pharmaceutical and biotech industries. It summarizes Hays Pharma's services and capabilities. Specifically, it details that Hays Pharma places over 2,500 professionals per year, has 23 offices globally, specializes in 15 functional areas of the pharmaceutical industry, and provides permanent, temporary, and project-based recruitment solutions tailored to clients' needs.
Medical Devices - Servicing Medical Device CompaniesIBMElectronics
The medical device industry is in the midst of fundamental change. IBM’s approach to servicing medical device companies is designed to meet real-world needs today and in the future.
Tom Brown is a highly accomplished Medical Sales Specialist and Director of Sales and Marketing with over 35 years of experience successfully selling medical equipment, devices, and supplies. He has consistently exceeded annual sales goals by 15% or more. As current Director of Sales and Marketing at Surgical Sales Solutions, Inc., he manages a team that sells a variety of surgical products to hospitals throughout the Southeast.
Home Medical Equipment Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...IMARC Group
The global home medical equipment market size reached US$ 37.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 53.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028.
More Info:- https://www.imarcgroup.com/home-medical-equipment-market
Similar to Upcoming Issue 31st April 2015 special issue exclusively on "Technology in Healthcare" (20)
Emotional and Behavioural Problems in Children - Counselling and Family Thera...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
CHAPTER 1 SEMESTER V COMMUNICATION TECHNIQUES FOR CHILDREN.pdfSachin Sharma
Here are some key objectives of communication with children:
Build Trust and Security:
Establish a safe and supportive environment where children feel comfortable expressing themselves.
Encourage Expression:
Enable children to articulate their thoughts, feelings, and experiences.
Promote Emotional Understanding:
Help children identify and understand their own emotions and the emotions of others.
Enhance Listening Skills:
Develop children’s ability to listen attentively and respond appropriately.
Foster Positive Relationships:
Strengthen the bond between children and caregivers, peers, and other adults.
Support Learning and Development:
Aid cognitive and language development through engaging and meaningful conversations.
Teach Social Skills:
Encourage polite, respectful, and empathetic interactions with others.
Resolve Conflicts:
Provide tools and guidance for children to handle disagreements constructively.
Encourage Independence:
Support children in making decisions and solving problems on their own.
Provide Reassurance and Comfort:
Offer comfort and understanding during times of distress or uncertainty.
Reinforce Positive Behavior:
Acknowledge and encourage positive actions and behaviors.
Guide and Educate:
Offer clear instructions and explanations to help children understand expectations and learn new concepts.
By focusing on these objectives, communication with children can be both effective and nurturing, supporting their overall growth and well-being.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
The Importance of Black Women Understanding the Chemicals in Their Personal C...bkling
Certain chemicals, such as phthalates and parabens, can disrupt the body's hormones and have significant effects on health. According to data, hormone-related health issues such as uterine fibroids, infertility, early puberty and more aggressive forms of breast and endometrial cancers disproportionately affect Black women. Our guest speaker, Jasmine A. McDonald, PhD, an Assistant Professor in the Department of Epidemiology at Columbia University in New York City, discusses the scientific reasons why Black women should pay attention to specific chemicals in their personal care products, like hair care, and ways to minimize their exposure.
PrudentRx: A Resource for Patient Education and Engagement
Upcoming Issue 31st April 2015 special issue exclusively on "Technology in Healthcare"
1. 1 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
Magazine
for the
Guardians
of
Healthcare
• Healthcare Management
• Medical Sciences
• Surgical Speciality
• Diagnostics
• Technology, Equipment & Devices
• Facilities & Operations Management
• Information Technology
MEDIA PACK
2. 2 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
What makes
Asian Hospital
& Healthcare
Management the
best advertising
platform?
The market for medical equipment and technology in Asia is
booming. In excess of US$24 billion is being spent each year with
major hospital construction projects underway in nearly all of the
Asian countries. Government spending on the health sector is
expected to grow at approximately 8-10% per annum.
A new private health sector is also emerging in response to growing
demand for quality health services. Suppliers to the Asian healthcare
markets anticipate a 20-30% growth rate over the next few years. The
need for the latest technology, materials and know-how in Asia is
therefore greater now than ever before.
Increasingly sophisticated management techniques and purchasing
methods also mean that competition amongst suppliers is intense.
Asian Hospital & Healthcare Management represents the most
advanced networking of industry information ever published in the
Asian markets and will be a required reading for hospital directors,
administrators and medical practitioners in both the public and
private sectors, together with top level representatives of Asia’s
health ministries.
3. 3 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
Through its circulation list, Asian Hospital & Healthcare Management
reaches the most powerful network of hospital decision makers in
the region. The purpose is to promote higher standards of healthcare
by providing a forum for the exchange of information in every aspect
of hospital services, patient care and latest medical technology.
Key Facts
Read by decision makers and specifiers at top hospital and•
healthcare institutions worldwide
Readership fully qualified by a dedicated team of researchers•
Projected readership of 180,000 decision makers•
Cutting-edge editorial content from industry experts•
Unique reader response system•
4. 4 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
target market
Asian Hospital & Healthcare Management reaches out to the top spending
private and public hospitals and medical laboratories in addition to the
national and regional health authorities and health ministries throughout
Asia. This guarantees that your advertisement reaches the right people.
Business Segments
Geographical Breakdown
Private Hospitals
42%
Public Hospitals
24%
Labs
23%
Suppliers
11%
Asia Pacific
70%
Europe
23%
America
1%
ROW
6%
5. 5 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
Target Audience
circulation
Asian Hospital & Healthcare Management guarantees that your
advertisement is reaching the right people in the right places.
Only the most influential decision makers receive Asian Hospital
& Healthcare Management.
The key job titles of industry readers who receive
Asian Hospital & Healthcare Management include:
C-Level
Chairman
President
Chief Executive Officer
Chief Finance Officer
Chief Information Officer
Chief Operating Officer
Chief Technology Officer
Chief Scientific Officer
Head of the Department
Head of Radialogy
Head of Cardiology
Head of Oncology
Head of Anesthesiology
Head of Diabetes
Head of Clinical Research
Head of Intensive Care Unit
Head of Marketing
Heads of all the healthcare
disciplines and departments
Business Management
Vice President
Executive Director
Managing Director
Administrator
Senior Advisors
Specialists
Specialists in Cardiology
Specialists in Oncology
Specialists in Anesthesiology
Specialists in all the disciplines
Professors in all the medical
sciences departments
Geographical Breakdown
C Level
Management
43%
Business
Management
30%Others
1% Head of
Deapartments
12%
Specialists
14%
6. 6 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
EDITORIAL
Asian Hospital & Healthcare Management presents insightful articles
on issues relevant to top management, technical articles and case
studies, analysis of the purchasing trends and technologies within
the key medical and healthcare disciplines including:
• Healthcare Management
• Medical Sciences
• Surgical Speciality
• Diagnostics
• Technology, Equipment & Devices
• Facilities & Operations Management
• Information Technology
Maximising your market potential
We work hard to ensure your message gets the opportunity
it deserves. We have pulled together an impressive stable of
contributors, experts and opinion formers to create the next issue of
Asian Hospital & Healthcare Management. Your advertisement will
appear alongside the most relevant article, ensuring it is seen by the
people who matter the most – your target market.
7. 7 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
Editorial
Contributors
Asian Hospital & Healthcare Management brings together
a most distinguished team of international experts and
industry chiefs drawn from medical institutions, hospitals
and industry associations. Past and present contributors
to Asian Hospital & Healthcare Management include:
Anne Rooney
Executive Director, International
Services, Joint Commission
International (JCI), USA
Peter A Gross
Chairman, Internal Medicine,
Hackensack University Medical Center,
USA
Judith D Mitchell
AIA I Director of Planning, Harvard
Medical International, USA
John R Adler
Professor, Neurosurgery and Director,
Radiosurgery and Stereotactic Surgery,
Stanford University School of Medicine,
USA
Madhav R Ragam
Director, Healthcare & Life Sciences,
IBM Asia Pacific, Singapore
Werner Van Huffel
Health and Social Services Industry
Strategist, Regional Public Sector
Group, Microsoft Asia Pacific,
Singapore
Ori Karev
CEO, UnitedHealth International, USA
R Carter Pate
Global and US Managing Partner,
Health Industries and Government
Services, PricewaterhouseCoopers
Health Research Institute,
USA
Sandy Lutz
Director, PricewaterhouseCoopers
Health Research Institute, USA
Amy Wilson-Stronks
Project Director, Division of Standards
and Survey Methods, Principal
Investigator, Hospitals, Language, and
Culture Study, The Joint Commission,
USA
Wayne Ruga
Founder and President, The CARITAS
Project, USA
Yosef D Dlugacz
Senior Vice President, Chief of Clinical
Quality Education and Research,
Krasnoff Quality Management Institute,
USA
Harald Pitz
Vice President, Industry Business
Unit Healthcare, Higher Education &
Research SAP AG, Germany
Kevin Dean
Managing Director, Connected Health,
Internet Business Solutions Group
(IBSG), Europe, Cisco Systems Inc.,
UK
Chris Chamberlain
Global Head, Medical Genetics, Roche
Products Limited, UK
Madhav R Ragam
Director, Healthcare & Life Sciences,
IBM Asia Pacific, Singapore
Allen Yeo
Principal Consultant, Thomson
Scientific, Singapore
Ramakanta Panda
Vice Chairman, Asian Heart Institute,
India Ronald B Herberman
Director, University of Pittsburgh
Cancer Institute, USA
Delon Wu
President, Taiwan Hospital Association,
Taiwan
Anneke E E Meursing
President, World Federation of
Societies of Anaesthesiologists, UK
8. 8 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
Reasons to
Advertise
with us
Circulation: A meticulously crafted circulation database
of companies that matter to you – A market place custom-
built to your needs
Readership: Readers are carefully chosen top
executives. A judicious blend of purchase decision makers
and specifiers - the individuals who matter most to your
company
Valuable Content: Insights and incisive analysis of
industry dynamics and emerging trends in technologies
including drug discovery, manufacturing etc., written by the
leading experts
Online Presence: Listing on the search engine
optimised website - Print advert doubling-up as online
vehicle
In sum, targeted marketing translating into ‘value for money’
1
2
3
4
5
9. 9 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
Advertising Rates
Custom publishing
In addition to the standard advertising options mentioned,
we also undertake custom publishing POA
Please contact at advertise@asianhhm.com to discuss
advertising and custom publishing opportunities
The publication is a high design, full
colour publication 210mm wide x
297mm deep. In order to maximise
the impact, a strictly limited number of
advertising positions have been made
available.
Note:
1. Advertisers are provided with one
copy of the publication only.
2. Requirement for extra copies
needs to be indicated at the time of
approving the advert. Such copies
entail extra charges @ $10 per
copy, plus cost of delivery
3. The above ad tariff is exclusive of the
Ad agency commission
4. Corporate Showcase (8-pages) option
entails flash of your logo on the cover
page bottom part (Size: 20 mm X 35
mm).
5. Font “Adobe Garamond Pro” is not
allowed for the contents of corporate
showcase.
Advertising Options..........Rates (In USD)
Double Page Spread............................... $8,900
Full Page................................................ $4,500
Half Page............................................... $2,450
1/3rd Page Vertical Outer....................... $1,475
1/3rd Page Product Flash...................... $750
Cover Positions
Outside Front Cover................................ $6,900
Inside Front Cover.................................. $5,800
Inside Back Cover.................................. $5,800
Special Positions
1. Corporate Showcase
A. 8-Pages, with flash on front cover.... $27,500
B. 4-Pages........................................... $14,850
2. Gatefold
A. Cover: 2-Pages................................ $10,850
B. Inner: 2-Pages................................. $10,500
3. Island................................................ $6,500
Banner Type Dimensions (px) Max File Size File Format Rates (USD)
Leader Board Banner 728x90 40kb GIF, JPEG, Flash SWF $2,000
Top/Full Banner 468x60 30kb GIF, JPEG, Flash SWF $1,500
Article / Interview 800 words MS Word $1,000
Direct Marketing
Pricing Structure
Direct Marketing campaigns are charged per e-mail address and the cost is (US $0.20) per address,
for mail shots above 15,000 units. For mail shots below 15,000 units, the charge is (US$0.25)
Booking example:
10,000 Direct Marketing messages cost:
10,000 x US$0.25 = US $2,500
Rate Card for Print Rate Card for Website
Rate Card for e-Newsletter
Banner Type Dimensions (px) Max File Size File Format Rates (USD)
Prime Banner 800x220 50kb GIF, JPEG, Flash SWF $8,500
Sky Tower Banner 300x600 50kb GIF, JPEG, Flash SWF $7,500
Leader Board Banner 728x90 40kb GIF, JPEG, Flash SWF $6,500
Top/Full Banner 468x60 30kb GIF, JPEG, Flash SWF $4,500
Base Banner 468x60 30kb GIF, JPEG, Flash SWF $3,000
Square Banner 300x250 25kb GIF, JPEG, Flash SWF $2,500
10. 10 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
Half Page Horizontal
Depth (A) Width (B)
Half page horizontal 124mm X 178mm
Double Page Spread
Depth (A) Width (B)
Double page type 255mm X 380mm
Double page trim 297mm X 420mm
Double page bleed 303mm X 432mm
Full Page
Depth (A) Width (B)
Full page type 255mm X 178mm
Full page trim 297mm X 210mm
Full page bleed 303mm X 216mm
(B)
(A) (A)
(B)
(A)
(B)
1/3rd Page Vertical Outer
Depth (A) Width (B)
1/3rd Page Vertical Outer 237mm X 52mm
(A)
(B)
1/6th Page Product Flash
Depth (A) Width (B)
1/6th Page Product Flash 70mm X 82mm
(A)
(B)
ISLAND
Depth (A) Width (B)
1/3rd Page Vertical Outer 80mm X 52mm
(A)
(B)
Mechanical Details
Gatefold Cover 2-Pages
Artwork
Software: InDesign, Photoshop, Illustrator & High resolution PDF (file must have all images at
300dpi with fonts embedded) (Not Compatible: PageMaker, CorelDraw or any other software or
files from the Internet)
Picture Resolution: 300dpi at 100% scaling for images, either as TIFF, JPG, EPS, or PDF
Colour: All colours to be CMYK breakdowns, including InDesign, Illustrator and Photoshop files
Fonts: Include all print and screen fonts
Depth (A) Width (B)
Gatefold Cover 2-Pages type 255mm X 380mm
Gatefold Cover 2-Pages trim 297mm X 420mm
Gatefold Cover 2-Pages bleed 303mm X 432mm
Cover
Page
Gatefold Cover
2-Pages
(B)
(A)
Gatefold Cover
2-Pages
Gatefold Inner 2-Pages
Page-1
Page-2
(B)
(A)
Depth (A) Width (B)
Gatefold Inner 2-Pages type 255mm X 380mm
Gatefold Inner 2-Pages trim 297mm X 420mm
Gatefold Inner 2-Pages bleed 303mm X 432mm
12. 12 / 12Email: advertise@asianhhm.com Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.asianhhm.com
1. Scope of our agreement: These are the conditions of the
contract between you, the client (“you” and “your”) and Ochre Media
(“Ochre Media”, “we”, “us” and “our”) relating to the provision by us
of advertising space in the magazine, as specified on your purchase
order.
2. Content and artwork responsibility: You are respon-
sible for providing all text and illustrations (“copy material”) for your
advertisement/s and any other insert/s (“advertisement”) in such a
format as Ochre Media may specify by the copy deadline specified on
your purchase order.
We shall prepare a proof of your advertisement and send across to
you for approval. If you wish to change any element of it, you must send
your changes to Ochre Media by the return date shown on the proof. If
we have not received any changes by the return date, we will assume
that you have approved the proof.
If you fail to supply copy material by the copy deadline, Ochre
Media reserves the right to repeat standing copy or to independently
determine the copy to be published (including sourcing from the public
domain). Failure by you to supply the necessary copy material for your
advertisement by the copy deadline will not affect your obligation to pay
for the advertisement in accordance with clause 4 below.
If your copy material is provided in a form different from that speci-
fied then you will be responsible for any reasonable extra costs that
may arise for preparing the material.
Notwithstanding the above, you agree that Ochre Media shall at
all times retain full editorial approval over the advertisement and that,
except as expressly provided in your purchase order, the positioning
of the advertisement shall be at Ochre Media’s sole discretion. Ochre
Media reserves the right at its absolute discretion to reject, withdraw
or amend text/information supplied by you for the advertisement and
such will not affect your obligation to pay for the advertisement in full in
accordance with clause 4.
3. Rights: In consideration of Ochre Media providing its advertising,
marketing and design services to you, you assign to Ochre Media full
title guarantee, for use throughout the world, the copyright (whether
vested, contingent or future) in the copy material supplied by you and
all rights of action in respect of that copy material.
The above will not operate as an assignment of your trade marks,
service marks and logos which will remain your property. Accordingly,
you hereby grant to Ochre Media a worldwide, non-exclusive, fully paid
licence to reproduce and display all trademarks, service marks and logos
contained within the copy material for the duration of this contract.
4. Invoice and settlement: An invoice for the amount specified
in your purchase order (plus applicable taxes) will be issued at the time
your advertisement is first published.
We will then invoice you for each renewed period (as defined in
clause 7) at Ochre Media’s then current rates on or shortly after the
relevant anniversary of the date of first publication. You may request
a copy of the rates that will apply in any renewed period from Ochre
Media at any time within three calendar months before the commence-
ment of that renewed period.
Settlement of all invoices is due 14 days from the date of the in-
voice. If your account falls overdue, then interest will be charged at the
rate of 12% per annum. This will be calculated on a daily basis from the
due date to the actual payment date. All prices quoted in the purchase
order are exclusive of applicable taxes.
5. Warranty and indemnity: You warrant and represent to Ochre
Media that: (i) you have all necessary rights to grant the rights and li-
cences set out in this contract to Ochre Media; (ii) neither the copy ma-
terial provided by you nor any material which may be linked to through
your advertisement will contain anything that is defamatory, obscene,
false or misleading or which otherwise violates any intellectual property
rights or other rights of any person; (iii) use of the copy material pro-
vided by you will not violate any applicable law or regulation.
You agree to indemnify and keep indemnified Ochre Media and hold
Ochre Media harmless against any and all damages, costs or fees aris-
ing from a breach of the above warranties including any claim or action
by a third party.
6. Liability: Ochre Media does not accept any liability for any dam-
ages (including, without limitation, damages for any consequential loss
or loss of business opportunities or projects, or loss of profits) how-
soever arising and whether in contract, tort or otherwise from the use
of or inability to use the advertisement, or any of its contents, or from
any action or omission taken as a result of using the advertisement or
any such contents. Ochre Media does not exclude liability for death or
personal injury arising out of its negligence.
You agree that Ochre Media has not made any guarantees with re-
spect to usage statistics, which include, without limitation, levels of
impressions or click-throughs for the advertisement.
7. Cancellation: This contract represents a legally binding com-
mitment between you and Ochre Media. You may only cancel your ad-
vertisement and terminate this contract in accordance with clause 7 or,
prior to the date your advertisement is first published, with the written
consent of Ochre Media. Ochre Media’s consent will be at its sole and
absolute discretion. If Ochre Media consents, prior to the date your
advertisement is first published, to your advertisement being cancelled
and this contract being terminated you will be liable to pay at least 50%
of the amount specified in your purchase order (plus applicable taxes)
and such amount will become payable within 14 days following the date
of Ochre Media’s written consent.
8. General: You may not resell, assign or transfer any of your rights
under this contract without Ochre Media’s prior written consent. Any at-
tempt to resell, assign or transfer rights without Ochre Media’s consent
will entitle Ochre Media to terminate this contract immediately without
liability to you.
A person who is not a party to this contract has no right to rely upon
or enforce any terms of this contract. In the event of a dispute arising
out of or in connection with these terms or any contract between you
and us, then you agree to attempt to settle the dispute by engaging in
good faith with us in a process of mediation before commencing arbi-
tration in accordance with The Arbitration and Conciliation Act, 1996.
This agreement is governed by and will be construed in accor-
dance with laws of India and each party irrevocably agrees that the
courts of Hyderabad shall have the exclusive jurisdiction to deal with
any disputes arising out of or in connection with this agreement. These
terms and conditions along with the purchase order constitute the entire
agreement and understanding between you and Ochre Media and su-
persede any previous agreement between the parties. You agree that all
the details of this contract appear in the purchase order and these terms
and conditions and that no employee of Ochre Media has made any
promise or commitment to you that does not appear here. Both parties
agree that the terms and conditions described here are binding and may
only be varied in writing signed by you and by a director of Ochre Media.
Nothing in this contract shall operate to limit or exclude liability for fraud.
Printed terms and conditions in any additional documents issued by you
or your agent will not be recognised as binding.
Terms & Conditions Conditions set out in the Joint Agreement for Advertisement